Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms

Rheumatology

Volumn 40, Issue 7, 2001, Pages 794-800

  Spisani, S ^a   Fabbri, E ^b   Muccinelli, M ^c   Cariani, A ^c   Barbin, L ^a   Trotta, F ^c   Dovigo, L ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

CsA; Cytosolic calcium; Neutrophil functionality; Receptor binding assay; Rheumatoid arthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIUM ION; CYCLOSPORIN A; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOSUPPRESSIVE AGENT; LYSOZYME; SUPEROXIDE;

ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; MEDICAL INFORMATION; MOLECULAR BIOLOGY; NEUTROPHIL; PRIORITY JOURNAL; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0034906183     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.7.794     Document Type: Article

References (33)

1. Cyclosporin in rheumatoid arthritis: A double-blind, placebo-controlled study in 52 patients
2. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
3. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A
4. Biological effect of cyclosporin A: A new antilymphocytic agent
5. Inhibition of phagocytes by cyclosporin in vitro
6. Mechanisms of action of second-line agents and choice of drugs in combination therapy
7. Immunological actions of cyclosporin A in rheumatoid arthritis
8. Cyclosporin A suppresses the induction of nitric oxide synthesis in interferon gamma-treated L929 fibroblasts
9. Antiangiogenesis by cyclosporine
10. Evidence that inhibition of phorbol ester-induced superoxide anion formation by cyclosporin A in phagocytes is not mediated by direct inhibition of protein kinase C
11. The effects of cyclosporin A on the immune system
12. Proteases and matrix degradation
13. Neutrophils in human diseases
14. 2+
15. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of a cell-derived chemotactic factor
16. Phe-Dleu-Phe-Dleu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: Cellular and conformational aspects
17. 2+ indicators with greatly improved fluorescence properties
18. Lactato dehydrogenase
19. Cytokines and acute phase proteins in rheumatoid arthritis
20. The neutrophil in rheumatoid arthritis
21. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: Priming and activation in vivo
22. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis
23. Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis
24. Defective expression of neutrophil membrane proteins in patients with rheumatoid arthritis
25. Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis
26. Impairment of neutrophil Fcγ receptor mediated transmembrane signalling in active rheumatoid arthritis
27. In vivo leukocyte migration in arthritis
28. Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus
29. Association of enhanced superoxide generation by neutrophil with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis. Effects of low acting drugs and disease activity
30. Rifamycins inhibit human neutrophil functions: New derivatives with potential anti-inflammatory activity
31. Cyclosporin H is a potent and selective formyl peptide receptor antagonist
32. c increase
33. FK-506 and cyclosporin A: Selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation